Grifols Update Regarding the Novel Coronavirus

The following is a statement provided by Grifols. “As the situation with the novel coronavirus rapidly evolves, we wanted to inform you that Grifols is taking measures in line with recommendations from the World Health Organization (WHO) to help ensure the safety of our employees, donors, products, and the patient communities we serve. We have […]

Novo Nordisk Pauses Clinical Trials Investigating Concizumab

The following is an excerpt from a press release published by Novo Nordisk. Novo Nordisk announced that two clinical trials in the concizumab phase 3 programme (explorer7 and 8) and one clinical trial in the phase 2 programme (explorer5) have been paused. The three clinical trials were investigating concizumab prophylaxis treatment in haemophilia A and […]

Novo Nordisk Letter to the Bleeding Disorders Community on COVID-19

The following is a letter provided by Novo Nordisk.  “You’ve come to know us as a part of the fabric of the hemophilia community for more than 30 years, always working to make things better for everyone affected by rare bleeding disorders. We know this is a challenging time for all as with the World Health […]